Downloads

The Patient Definition, Eligibility & Required Documentation

This white paper provides an overview of the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration’s (HRSA) 340B Drug Discount Pricing Program with a particular focus on aspects of legislation and regulation that impact patient definition and referral prescriptions.

Access Whitepaper

Features in-depth analysis of patient definition by describing:

HHS and Apexus positions with respect to patient and provider eligibility.
Current and historical guidelines on patient definition with an emphasis on referral prescriptions.
An exclusive data analysis from eight 340B CE contract pharmacies and vendor partners revealing overall referral prescription capture rate at 2% and specialty capture nearly absent.
Operational and technical challenges involved in capturing referral prescriptions in a manner that satisfies HRSA audits.
How 340B Recovery solves current challenges.